20. Jacobson D, Singer M. The cell, the mitochondrion, oxygen and sepsis. En: Vincent JL (eds). Yearbook of Intensive Care and Emergency Medicine. Heidelberg: Springer-Verlag; 1996. p. 263-274.

21. Komatsu T, Shibutani K, Okamoto K, Kumar V, Kubal K, Sanchala V et al. Critical level of oxygen delivery after cardiopulmonary bypass. Crit Care Med 1987; 15:194-197.

22. Moral V. Sangre y Derivados. En: Cuidados críticos, Medicina de Urgencias, sangre y transfusión. Cataluña: FEEA; 2004. p. 199-210.

23. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU: is there a reason? Chest 1995; 108:767-71.

24. Fuentes C, Rubio JM. Transfusión de sangre y hemoderivados. En: Manual de Medicina Intensiva. 2ª Edición. Madrid: Ediciones Harcourt, SA; 2001. p. 391-7.

25. Goodnough LT, Brecher ME, Kanter MH. Transfusion Medicine. N Engl J Med 1999; 340 (6): 525-33.

26. Shapiro MJ, Gettinger A, Corwin HL, et al. Anemia and blood transfusion in trauma patients admitted to the intensive care unit. J Trauma 2003; 55:269-74.

27. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024-3029.

28. McFarland JG. Perioperative blood Transfusión: indications and options. Chest 1999; 115 (5): 113-121.

29. Hébert PC. Reassessing Transfusion Strategies in Critically Ill Patients: Is a Restrictive Approach Better Than a Liberal One?. N Engl J Med 1999; 340 (6): 409-17.

30. Alfonso ME. Sustitutos de la sangre. Rev Cubana Hematol Inmunol Hemoter 2001; 17 (2): 90-7.

31. Standl T. Autologous transfusion - from euphoria to reason: clinical practice based on scientific knowledge. Artificial oxygen carriers: cell-free hemoglobin solutions—current status. Anasthesiol Intensivmed Notfallmed Schmerzther 2005; 40 (1):38-45.

32. Talarico TL, Guise KJ, Stacey CJ. Chemical characterization of pyridoxalated hemoglobin polyoxyethylene conjugate. Biochim Biophys Acta 2000; 1476 (1): 53-65.

33. Bi Z, He X, Zhang X, Jiang Y, Zhao Km, Liu Q. Pharmacodynamic study of polyethylene glycol conjugated bovine hemoglobin (PEG-bHb) in rats. Artif Cells Blood Substit Immobil Biotechnol 2004; 32 (2):173-87.

34. Chan WL, Tang NL, Yim CC, Lai FM, Tam MS. New features of renal lesion induced by stroma free hemoglobin. Toxicol Pathol 2000; 28 (5):635-42.

35. Menu P, Bleeker W, Longrois D, Caron A, Faivre-Fiorina B. In vivo effects of Hb solutions on blood viscosity and rheologic behavior of RBCs: comparison with clinically used volume expanders. Transfusion 2000; 40 (9):1095-103.

36. Drobin D, Kjellstrom BT, Malm E. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4). J Appl Physiol 2004; 96 (5):1843-53.

37. Fitzpatrick CM, Savage SA, Kerby JD, Clouse WD,Kashyap VS. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage. J Am Coll Surg 2004; 199 (5):693-701.

38. Vandegriff KD, Bellelli A, Samaja M, Malavalli A, Brunori M, Winslow RM. Kinetics of NO and O2 binding to a maleimide poly (ethylene glycol)-conjugated human haemoglobin. Biochem J 2004; 382 (1):183-9.

39. Rebel A, Ulatowski JA, Kwansa H. Cerebrovascular response to decreased hematocrit: effect of cell-free hemoglobin, plasma viscosity, and CO2. Am J Physiol Heart Circ Physiol 2003 Oct; 285 (4):1600-8.

40. Caswell JE, Strange MB, Rimmer DM. A novel hemoglobin-based blood substitute protects against myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2005; 288 (4):1796-801.

41. Matsumoto T, Asano T, Mano K, Tachibana H. Regional myocardial perfusion under exchange transfusion with liposomal hemoglobin: in vivo and in vitro studies using rat hearts. Am J Physiol Heart Circ Physiol 2005; 288 (4):1909-14.

42. Alayash AI. Hemoglobin-based blood substitutes and the hazards of blood radicals. Free Radic Res 2000; 33 (4):341-8.

43. Zhao DX, Wei XG, Gu ZY, Zhang GF. Preparation of bovine lipid-free hemoglobin. Sheng Wu Gong Cheng Xue Bao 2002 Sep;18 (5):609-13.

44. Anton N; Hitzler JK; Kavanagh BP. Treatment of life-threatening post-haemorrhagic anaemia with cell-free haemoglobin solution in an adolescent Jehovah's Witness. Br J Haematol 2002; 118 (4):1183-6.

45. Creteur J, Vincent JL. Hemoglobin solutions. Crit Care Med 2003; 31 (12): 698-707.

46. Creteur J, Sibbald W, Vincent JL. Hemoglobin solutions--not just red blood cell substitutes. Crit Care Med 2000; 28 (8):3025-34.

47. Leone BJ. Potential Clinical applications of recombinant human haemoglobin in blood conservation. BioDrugs 1999 Mar; 11 (3): 211-21.

48. Viele MK, Weiskopf RB, Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 1997; 86: 848-58.

49. Spahn DR. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 1999; 3 (5):93-7.

50. Perevedentseva EV, Zaritskiy AR. Perfluorocarbon emulsions increase transfer of oxygen in plasma from erythrocyte to tissues. Artif Cells Blood Substit Immobil Biotechnol 1998; 26 (2):223-9.

51. Mitsuno T, Ohyanagi H. Clinical studies of a perfluorochemical whole blood substitute. Ann Surg 1982; 195:60-9.

52. Clark MC, Weiman DS, Pate JW, Gir S. Perfluorocarbons: future clinical possibilities. J Invest Surg 1997; 10 (6):357-65.

53. Rebel A, Frietsch T, Quintel M, Lenz C. Cerebral effects of perfluorocarbons. Nervenarzt 1999; 70 (8):679-87.

54. Cochran RP, Kunzelman KS, Vocelka CR, Akimoto H. Perfluorocarbon emulsion in the cardiopulmonary bypass prime reduces neurologic injury. Ann Thorac Surg 1997; 63 (5):1326-32.

55. Kauczor HU, Hanke A, Van Beek EJ. Assessment of lung ventilation by MR imaging: current status and future perspectives. Eur Radiol 2002; 12 (8):1962-70.

56. Rudiger M, Wissel H, Ochs M. Perfluorocarbons are taken up by isolated type II pneumocytes and influence its lipid synthesis and secretion. Crit Care Med 2003; 31 (4):1190-6.

57. Bourke RD, Cooling RJ. Perfluorocarbon heavy liquids. Aust N Z J Ophthalmol 1995; 23 (3):165-71.

58. McLaren AJ, Friend PJ. Trends in organ preservation. Transpl Int 2003 Oct; 16 (10):701-8.

59. Kuznetsova IN. Stability of perfluorocarbon emulsions and their compatibility with blood serum. Artif Cells Blood Substit Immobil Biotechnol 1998; 26 (2):181-9.